Cell cycling status of human cord blood CD34+ cells during ex vivo expansion is related to the level of very late antigen expression

J Korean Med Sci. 2001 Feb;16(1):20-4. doi: 10.3346/jkms.2001.16.1.20.

Abstract

Very late antigen-4 (VLA-4), which binds to the extracellular matrix protein fibronectin, is an integrin molecule known to be modulated during mobilization of CD34+ cells, and to be involved in signaling the mobilization stimuli. On the hypothesis that cell cycling status might be different depending on the level of VLA-4 expression, we investigated the DNA contents of human cord blood CD34+ cells during ex vivo expansion by recombinant human thrombopoietin and flt3-ligand with simultaneous measurement of surface VLA-4 at the 1st and 4th week. During this ex vivo expansion, expression of VLA-4 increased and almost all cells became VLA-4+ until the 4th day of culture. Expression of VLA-4 was maintained in the major population of the cultured cells until the 4th week. The cells in S/G2/M phase were greater in number in VLA-4 high fraction than in VLA-4 low fraction (n=4, p<.001). Furthermore, the fraction of cells in S/G2/M phase increased as the expression of VLA-4 became higher. These results suggest that cord blood CD34+ cells expressing high levels of VLA-4 have more proliferative activities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD34 / analysis*
  • Cells, Cultured
  • DNA / analysis
  • Fetal Blood / cytology*
  • G2 Phase
  • Hematopoietic Stem Cells / physiology*
  • Humans
  • Immunophenotyping
  • Infant, Newborn
  • Integrin alpha4beta1
  • Integrins / analysis*
  • Receptors, Lymphocyte Homing / analysis*
  • S Phase

Substances

  • Antigens, CD34
  • Integrin alpha4beta1
  • Integrins
  • Receptors, Lymphocyte Homing
  • DNA